Neurosteroid Modulation of Synaptic and Extrasynaptic GABA
allopregnanolone
brexanolone
nucleus accumbens
phasic inhibition
tonic inhibition
zuranolone GABAA receptor
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
09 Apr 2024
09 Apr 2024
Historique:
received:
14
02
2024
revised:
29
03
2024
accepted:
04
04
2024
medline:
27
4
2024
pubmed:
27
4
2024
entrez:
27
4
2024
Statut:
epublish
Résumé
The recent approval of formulations of the endogenous neurosteroid allopregnanolone (brexanolone) and the synthetic neuroactive steroid SAGE-217 (zuranolone) to treat postpartum depression (PPD) has encouraged further research to elucidate why these potent enhancers of GABA
Identifiants
pubmed: 38672476
pii: biom14040460
doi: 10.3390/biom14040460
pii:
doi:
Substances chimiques
Receptors, GABA-A
0
Neurosteroids
0
Pregnanolone
BXO86P3XXW
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : Studentship 1313951
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 221617/Z/20/Z
Pays : United Kingdom